BREAKING
Home » Archive by Category "Vaccines" (Page 107)

Meningitis B vaccine, Trumenba, receives FDA approval: 1st in the US

By

The U.S. Food and Drug Administration announced today the approval of Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis...

Colorado State University manufacturing Ebola, Marburg vaccines for DOD

By

NEWS RELEASE Colorado State University is aiding in the development of vaccines to protect U.S. soldiers from Ebola and Marburg, both deadly diseases caused by filoviruses. BioMARC, a high-containment...

Swissmedic approves human trial with experimental Ebola vaccine in Lausanne

By

The World Health Organization (WHO) welcomes the approval by Swissmedic, the Swiss regulatory authority for therapeutic products, for a trial with an experimental Ebola vaccine at the Lausanne University...

Johnson & Johnson to begin testing Ebola vaccine in January

By

Johnson & Johnson today announced that it has made a commitment of up to $200 million to accelerate and significantly expand the production of an Ebola vaccine program in development at its Janssen...

SDSU student had meningitis serotype B, US vaccines don’t protect against

By

The strain of Neisseria meningitis, the agent of meningococcal disease, that killed 18-year-old  San Diego State University (SDSU) freshman Sara Stelzer is the same strain seen in outbreaks of meningococcal...

‘No longer-term association of vaccines with multiple sclerosis (MS)’ : study

By

A study to determine whether vaccines, particularly those for hepatitis B (HepB) and human papillomavirus (HPV), increased the risk of multiple sclerosis (MS) or other acquired central nervous system demyelinating...

Canada to ship 800 vials of experimental Ebola vaccine Monday

By

The Government of Canada will ship 800 vials of its experimental Ebola vaccine to the World Health Organization (WHO) in Geneva, beginning with its first shipment on Monday, October 20, 2014. The vaccine...

3rd Ebola vaccine’s development to advance with BARDA funding

By

The development of a vaccine to prevent Ebola virus disease will be accelerated with support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness...

Rotavirus vaccine begins phase III clinical trial in India

By

Sanofi Pasteur, the vaccines division of Sanofi, announced today the start of a phase III clinical trial in India for its investigational rotavirus vaccine, developed and manufactured by its affiliate...

Ebola vaccine: Phase 1 trials on Canada’s VSV-EBOV launched in US

By

Canada’s Minister of Health, Rona Ambrose, announced Monday the the launch of Phase 1 clinical trials for Canada’s Ebola vaccine (VSV-EBOV) at the Walter Reed Army Institute of Research in Silver...